lobbying_activities: 1273358

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1273358	caa844cd-bc52-48b4-aad7-2d0ac659e9a8	Q2	THE DUBERSTEIN GROUP INC.	12675	AMERICA'S HEALTH INSURANCE PLANS	2012	second_quarter	PHA	FEHBP prescription drugs - HR 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. Pay-for-delay settlements - S 27, Preserve Access to Affordable Generics Act. Antitrust exemption for independent pharmacies - HR 1946, Preserving Our Hometown Independent Pharmacies Act of 2011. FDA user fee programs - HR 3988, Generic Drug and Biosimilar User Fee Act of 2012. Pay-for-delay settlements - HR 3995, Protecting Consumer Access to Generic Drugs Act of 2012. FDA oversight of medical devices - S 2193, Ensuring Safe Medical Devices for Patients. Pharmaceutical, medical device issues - HR 5651, Food and Drug Administration Reform Act of 2012; S 2516, Food and Drug Administration Safety and Innovation Act; S 3187, Food and Drug Administration Safety and Innovation Act. Standards for on-line pharmacies - S 2002, Online Pharmacy Safety Act.	HOUSE OF REPRESENTATIVES	100000		0	0	2012-07-19T11:21:11.167000-04:00